Logo image of CPIX

CUMBERLAND PHARMACEUTICALS (CPIX) Stock Overview

NASDAQ:CPIX - US2307701092 - Common Stock

3.49 USD
+0.02 (+0.58%)
Last: 8/29/2025, 8:14:17 PM
3.57 USD
+0.08 (+2.29%)
After Hours: 8/29/2025, 8:14:17 PM

CPIX Key Statistics, Chart & Performance

Key Statistics
52 Week High7.25
52 Week Low1.04
Market Cap52.21M
Shares14.96M
Float8.74M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.14
PE24.93
Fwd PEN/A
Earnings (Next)11-05 2025-11-05
IPO08-11 2009-08-11
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


CPIX short term performance overview.The bars show the price performance of CPIX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20

CPIX long term performance overview.The bars show the price performance of CPIX in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150

The current stock price of CPIX is 3.49 USD. In the past month the price decreased by -0.85%. In the past year, price increased by 158.52%.

CUMBERLAND PHARMACEUTICALS / CPIX Daily stock chart

CPIX Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 45.36 693.36B
JNJ JOHNSON & JOHNSON 17.72 426.69B
NVO NOVO-NORDISK A/S-SPONS ADR 14.44 250.88B
AZN ASTRAZENECA PLC-SPONS ADR 18 247.73B
NVS NOVARTIS AG-SPONSORED ADR 14.3 244.98B
MRK MERCK & CO. INC. 10.92 210.11B
PFE PFIZER INC 7.3 140.77B
SNY SANOFI-ADR 11.17 120.68B
BMY BRISTOL-MYERS SQUIBB CO 7.01 96.03B
GSK GSK PLC-SPON ADR 8.76 79.97B
ZTS ZOETIS INC 25.14 69.31B
TAK TAKEDA PHARMACEUTIC-SP ADR 49.97 47.34B

About CPIX

Company Profile

CPIX logo image Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The company is headquartered in Nashville, Tennessee and currently employs 91 full-time employees. The company went IPO on 2009-08-11. The firm is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) injection, for the treatment of pain and fever; Kristalose (lactulose) for oral solution, a prescription laxative, for the treatment of constipation; Sancuso (granisetron) transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ (telavancin) injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.

Company Info

CUMBERLAND PHARMACEUTICALS

2525 West End Avenue, Suite 950

Nashville TENNESSEE 37203 US

CEO: A. J. Kazimi

Employees: 91

CPIX Company Website

CPIX Investor Relations

Phone: 16152550068

CUMBERLAND PHARMACEUTICALS / CPIX FAQ

What is the stock price of CUMBERLAND PHARMACEUTICALS today?

The current stock price of CPIX is 3.49 USD. The price increased by 0.58% in the last trading session.


What is the ticker symbol for CUMBERLAND PHARMACEUTICALS stock?

The exchange symbol of CUMBERLAND PHARMACEUTICALS is CPIX and it is listed on the Nasdaq exchange.


On which exchange is CPIX stock listed?

CPIX stock is listed on the Nasdaq exchange.


What is CUMBERLAND PHARMACEUTICALS worth?

CUMBERLAND PHARMACEUTICALS (CPIX) has a market capitalization of 52.21M USD. This makes CPIX a Micro Cap stock.


How many employees does CUMBERLAND PHARMACEUTICALS have?

CUMBERLAND PHARMACEUTICALS (CPIX) currently has 91 employees.


What are the support and resistance levels for CUMBERLAND PHARMACEUTICALS (CPIX) stock?

CUMBERLAND PHARMACEUTICALS (CPIX) has a support level at 3.32 and a resistance level at 3.5. Check the full technical report for a detailed analysis of CPIX support and resistance levels.


Should I buy CUMBERLAND PHARMACEUTICALS (CPIX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CUMBERLAND PHARMACEUTICALS (CPIX) stock pay dividends?

CPIX does not pay a dividend.


When does CUMBERLAND PHARMACEUTICALS (CPIX) report earnings?

CUMBERLAND PHARMACEUTICALS (CPIX) will report earnings on 2025-11-05.


What is the Price/Earnings (PE) ratio of CUMBERLAND PHARMACEUTICALS (CPIX)?

The PE ratio for CUMBERLAND PHARMACEUTICALS (CPIX) is 24.93. This is based on the reported non-GAAP earnings per share of 0.14 and the current share price of 3.49 USD. Check the full fundamental report for a full analysis of the valuation metrics for CPIX.


What is the Short Interest ratio of CUMBERLAND PHARMACEUTICALS (CPIX) stock?

The outstanding short interest for CUMBERLAND PHARMACEUTICALS (CPIX) is 0.24% of its float. Check the ownership tab for more information on the CPIX short interest.


CPIX Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to CPIX. When comparing the yearly performance of all stocks, CPIX is one of the better performing stocks in the market, outperforming 94.13% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

CPIX Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to CPIX. The financial health of CPIX is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CPIX Financial Highlights

Over the last trailing twelve months CPIX reported a non-GAAP Earnings per Share(EPS) of 0.14. The EPS increased by 207.69% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -4.32%
ROE -10.47%
Debt/Equity 0.19
Chartmill High Growth Momentum
EPS Q2Q%100%
Sales Q2Q%10.05%
EPS 1Y (TTM)207.69%
Revenue 1Y (TTM)11.34%

CPIX Forecast & Estimates


Analysts
Analysts43.33
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

CPIX Ownership

Ownership
Inst Owners28.76%
Ins Owners3.46%
Short Float %0.24%
Short Ratio0.22